Tongmai Yangxin pill alleviates myocardial no-reflow by activating GPER to regulate HIF-1α signaling and downstream potassium channels

AbstractContext The Tongmai Yangxin pill (TMYX) has potential clinical effects on no-reflow (NR); however, the effective substances and mechanisms remain unclear.Objective This study evaluates the cardioprotective effects and molecular mechanisms of TMYX against NR.Materials and methods We used a my...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ting Chen (Author), Yulong Zhang (Author), Manyun Chen (Author), Pu Yang (Author), Yi Wang (Author), Wei Zhang (Author), Weihua Huang (Author)
Formato: Libro
Publicado: Taylor & Francis Group, 2023-12-01T00:00:00Z.
Subjects:
Acceso en liña:Connect to this object online.
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Dispoñible